Targeting not only reduced Hb levels, but more comprehensively the eNOS-related mechanisms of RBC dysfunction, and improving the cardio-circulatory adaptation may provide novel therapeutic approaches in patients with anaemia and superimposed AMI. This evidence concerns the gene NOS3 and anemia (phenotype).